London, June 5 Women with a genetic abnormality in their cancer given a new gene drug, combined with hormone therapy, improved their survival rate, according to trial results. The results, published in the Lancet Oncology journal, showed the breast cancer patients who were given Capivasertib, developed by AstraZeneca, survived almost ...

London, June 3 An estimated 2 million people in Britain have lingering Covid-19 symptoms more than four weeks after their initial coronavirus infection, a latest survey showed. Based on the Office for National Statistics (ONS) survey of people living in private households in Britain, an estimated 3.1 per cent of ...